Navigation Links
Paper Published in American Journal of Cardiology Demonstrates Favorable Vascular Healing Following MiStent SES Implantation
Date:11/21/2013

s. Its unique surface and polymer modification technologies enable Micell to precisely and consistently control drug elution and polymer exposure duration, creating the potential for a therapeutic solution to coronary artery disease without the long-term safety concerns of currently available drug-eluting stents. Micell also is developing a drug-coated balloon for vascular interventions. Learn more about the company at www.micell.com.  

Caution Regarding Forward-Looking Statements

This press release contains forward-looking statements that can be identified by the fact that they do not relate strictly to historical or current facts. Forward looking statements include words such as "anticipates," "estimates," "expects," "projects," "intends," "plans," "believes" and words and terms of similar substance in connection with the ability of MiStent SES® to control drug elution and limit polymer exposure duration and its ability to reduce safety risks as compared to conventional permanent polymer drug eluting stents.  We caution readers that the forward looking statements contained in this press release are predictions based on our current analysis of and expectations about future events and speak only as of the date of this press release. These forward looking statements are not guarantees of future performance and are subject to risks and uncertainties, including, but not limited to the following: the results of any further clinical trials and studies, including long-term follow up of the patients that have undergone the DESSOLVE I and DESSOLVE II clinical studies; our ability to obtain regulatory approval of the MiStent SES in other jurisdictions; the successful development and commercialization of the MiStent SES in Europe and other markets; the ability of the MiStent SES to effectively and successfully compete with current commercially available drug-eluting stent te
'/>"/>

SOURCE Micell Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. PaperFree Pharmacy Generation 3 Hits the Market
2. Panacea Pharmaceuticals Presents Three Papers Regarding Its Nanoparticle-Based Therapeutic Cancer Vaccine at the Society for Immunotherapy of Cancer Annual Meeting at National Harbor, MD
3. Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer - International White Paper Launched at European Cancer Congress 2013
4. Absorption Systems Scientists Publish Peer-reviewed Paper on a Key Drug Transporter
5. Automation is Revolutionizing White Cell Differential Analysis; New Whitepaper Details How
6. Angelus says Home Office Banning Legal High Benzo Fury is "Papering over the Cracks"
7. RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care
8. 150,000 Medical Professionals Stay Paperless with Practice Fusion
9. New White Paper Details What Compounding Pharmacies Must Know to Prepare for FDA Inspections
10. TechMed Charts: New Specialists in Thermal Papers and Supplies for Patient Monitoring and Process Control
11. Disinfectant Qualification Questions are Answered for Sterile Drug Manufacturers in New White Paper
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... S.C. , Sept. 18, 2014   3D Systems ... of the Simbionix RobotiX Mentor™ , a new robotic ... for the first time at the ERUS exhibition in ... 19 (booth #7). Robotic-assisted minimally invasive surgery represents ... demand means the needs for training for robotic surgery has ...
(Date:9/18/2014)... MELBOURNE, Australia , Sept. 18, 2014 ... appointments of Dr. Ashraf Hanna , M.D., Ph.D., ... its Board of Directors. Dr. Hanna is the Vice ... and Chief Financial Officer for the Genentech Foundation, while ... Global Head of Business Development and Licensing for Roche ...
(Date:9/18/2014)... Mass. , Sept. 18, 2014  Spring ... novel therapeutics for the treatment of RNA viruses, ... Institutes of Health (NIH) for animal testing of ... viral pathogens, classified as "Special Pathogens," against which ... 9200, derived from Spring Bank,s proprietary ...
Breaking Medicine Technology:3D Systems Introduces New Simbionix Robotics Training Platform 23D Systems Introduces New Simbionix Robotics Training Platform 3Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2
... BRUNSWICK, N.J., Aug. 10, 2011 Savient Pharmaceuticals, Inc. (Nasdaq: ... Chief Executive Officer and President of Savient will present at ... Tuesday, August 16, 2011, at 4:10 p.m. Eastern Time.  The ... New York, NY. A live webcast of ...
... 10, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) ... and development outsourcing company serving the pharmaceutical, biotechnology, and medical ... today announced its financial results for the second quarter of ... Quarterly Net Revenues Exceeded $100 Million for the First Time ...
Cached Medicine Technology:WuXi PharmaTech Announces Second Quarter 2011 Results 2WuXi PharmaTech Announces Second Quarter 2011 Results 3WuXi PharmaTech Announces Second Quarter 2011 Results 4WuXi PharmaTech Announces Second Quarter 2011 Results 5WuXi PharmaTech Announces Second Quarter 2011 Results 6WuXi PharmaTech Announces Second Quarter 2011 Results 7WuXi PharmaTech Announces Second Quarter 2011 Results 8WuXi PharmaTech Announces Second Quarter 2011 Results 9WuXi PharmaTech Announces Second Quarter 2011 Results 10WuXi PharmaTech Announces Second Quarter 2011 Results 11WuXi PharmaTech Announces Second Quarter 2011 Results 12WuXi PharmaTech Announces Second Quarter 2011 Results 13WuXi PharmaTech Announces Second Quarter 2011 Results 14WuXi PharmaTech Announces Second Quarter 2011 Results 15WuXi PharmaTech Announces Second Quarter 2011 Results 16WuXi PharmaTech Announces Second Quarter 2011 Results 17
(Date:9/18/2014)... 18, 2014 Throughout their lives, sisters ... other on, celebrate their achievements and accomplishments together, and ... and joy. , Joanie’s Sisters in Support, a support ... joined together by their battles against breast and ovarian ... which was organized in June, meets once a month ...
(Date:9/18/2014)... HealthDay Reporter THURSDAY, Sept. 18, 2014 (HealthDay ... therapy effectively treats normally sagging levels of the hormone in ... panel said Wednesday. The panel, from two key FDA ... drugs and require drug makers to conduct tests assessing the ... Bloomberg News . "The whole idea is to try ...
(Date:9/18/2014)... PLAINS, NY, SEPT. 18, 2014 -- Only about half ... shot each season, leaving thousands of moms-to-be and their babies ... a flu shot should be a routine part of prenatal ... officer. "Health care providers should offer their pregnant patients a ... should ask for it." , A report by the U.S. ...
(Date:9/18/2014)... 2014) -- Two independent groups of researchers led ... of Kentucky, and Charles Lowenstein, MD, of the ... the role that a gene called STXBP5 plays ... to Whiteheart, previous genome-wide association studies (GWAS) identified ... regulates a protein called Von Willebrand factor (VWF). ...
(Date:9/18/2014)... is available in German . ... strategy not to fight a pathogen tooth and nail, but rather ... One key feature of tolerance is that the disease only progresses ... carries a high pathogen load. , Roland Regoes, a senior scientist ... approach to HIV. He set about investigating whether there are infected ...
Breaking Medicine News(10 mins):Health News:Artist’s Cancer Jewelry to Benefit Joanie’s Sisters 2Health News:Artist’s Cancer Jewelry to Benefit Joanie’s Sisters 3Health News:FDA Panel: Limit Testosterone Drug Use 2Health News:FDA Panel: Limit Testosterone Drug Use 3Health News:FDA Panel: Limit Testosterone Drug Use 4Health News:Flu vaccine for expectant moms a top priority 2Health News:University of Kentucky research explores STXBP5 gene and its role in blood clotting 2Health News:Withdrawal from the evolutionary race 2Health News:Withdrawal from the evolutionary race 3
... ... in Christ for A Day of Breast Health Awareness, Education and Screenings , ... Philadelphia, Pa. (Vocus) October 2, 2009 -- ... with Praise is The Cure and the Health Ministry Program will have a day-long celebration ...
... ... with chronic sinusitis and recurring sinus infections. When antibiotics fail they are left with little ... ... SinusWars LLC has been treating sinus related conditions for years and has noticed an increase ...
... "Profile America" feature from the U.S. Census Bureau: , (Logo: ... 2: FIRST GYM INSTRUCTORS , Profile America ... staying fit. Often, they have exercise equipment at home, ... But most people interested in fitness plan their busy ...
... has discovered a new way to classify stomach cancers, ... toward designing more effective treatments and improving long-term survival. ... and represents the second leading cause of cancer deaths ... from patients in Singapore, Australia and the United Kingdom ...
... 1 Two interactive computer tools released today by ... emergency planners and responders select and run alternate care ... a surge in seriously ill patients requiring acute care ... alternate care sites. , Alternate care facilities ...
... ... of hydrolysates, the performance of FBS and the consistency of a defined media. , ... Fort Collins, CO (PRWEB) October 4, ... hamster ovaries) cell line enhancement called Zap-CHO . Zap-CHO is designed to deliver superior ...
Cached Medicine News:Health News:More than 500 Breast Cancer Survivors and Community Supporters to Attend Annual 'Praise is The Cure' Event 2Health News:SinusWars LLC Launches a Successful and All Natural Alternative to Antibiotics in the Fight to Treat Chronic Sinusitis 2Health News:Duke/Singapore scientists find new way to classify gastric cancers 2Health News:New Tools Help Emergency Planners Select Alternate Care Facilities and Transfer Patients During Disasters 2Health News:InVitria Launches Zap-CHO to Enhance CHO Cell Culture Performance 2Health News:InVitria Launches Zap-CHO to Enhance CHO Cell Culture Performance 3
10 L, Racked, 96 tips/rack Extended length pipette tips recommended for 5 and 10 L pipettes....
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 ul reference mark make it ideal for low volume pipetting....
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
... Diagnostics West Nile Virus IgG DxSelect ... to West Nile virus in human,serum. ... West Nile Virus,IgM Capture DxSelect, the ... symptoms of meningioencephalitis, as an aid ...
Medicine Products: